borderline significancep=0.05
Specifically, GLS exhibited a decrease during chemotherapy compared to the baseline, demonstrating borderline significance 18.5±2.3 versus -19.6±1.6 (p=0.05).
Specifically, GLS exhibited a decrease during chemotherapy compared to the baseline, demonstrating borderline significance 18.5±2.3 versus -19.6±1.6 (p=0.05).